Monitor for effectiveness of the registration statement and subsequent trading commencement. The 12-month deadline creates urgency for deal execution — any announcement of a target or extension vote will be a catalyst. China regulatory overhang and Hong Kong-based management may limit target pool and increase deal risk.
Executive Summary
AfterNext Acquisition I Corp. filed Amendment No. 9 to its S-1 for a $100 million SPAC IPO, marking another step toward effectiveness. Each unit consists of one Class A share, one right (1/4th share upon business combination), and one warrant ($11.50 exercise price). The company will target fintech/tech-enabled financial services in Asia-Pacific (excluding China, Hong Kong, Macau), but management and sponsor ties to Hong Kong create China regulatory risk. The 12-month deadline to complete a business combination creates time pressure.
Key Facts
- Offering size: $100,000,000 (10,000,000 units at $10.00 per unit)
- Each unit: 1 Class A share + 1 right (1/4 share upon business combination) + 1 warrant ($11.50 exercise)
- Trust account: $100,500,000 ($10.05 per public share) from offering, private placement, and ARC deposit
- 12-month deadline from closing to complete a business combination
- Will not pursue targets based in Mainland China, Hong Kong, or Macau
- Sponsor holds 3,833,333 founder shares purchased for $25,000 (~$0.007/share)
- Sponsor to purchase 275,000 private units at $10.00/unit ($2,750,000 total)
- Underwriters have 45-day option for up to 1,500,000 additional units
- Company has no revenue, no operations, and no target identified
Financial Impact
$100.5 million in trust account ($10.05 per share) for business combination; $900,000 working capital outside trust; sponsor investment of $2.775 million at risk if no deal closes
Risk Factors
- China regulatory risk due to Hong Kong-based sponsor, officers, and directors
- 12-month deadline to complete business combination creates time pressure
- No target identified — substantial doubt about ability to continue as going concern
- Founder shares purchased at ~$0.007/share create misaligned incentives with public shareholders
- CFIUS review risk for U.S. targets due to non-U.S. sponsor control
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001493152-26-041834 |
| Exhibit: ex1-1.htm | 0001493152-26-041834 |
| Exhibit: ex10-3.htm | 0001493152-26-041834 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 8, 2026 6w ago | S-1/A | — | awaiting T+20 | — | — |
Aug 10, 2026 11w ago | S-1/A | — | awaiting T+20 | — | — |
Jul 8, 2026 15w ago | S-1/A | — | awaiting T+20 | — | — |
Mar 19, 2026 31w ago | S-1/A | — | awaiting T+20 | — | — |
Mar 2, 2026 34w ago | S-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers